谷参肠胺治疗腹泻型肠道易激综合征的临床观察

Therapeutic Effect of Gu Shen Chang An in the Treatment of Irritable Bowel Syndrome of Diarrheal Type

对比观察谷参肠胺和芽胞杆菌类制剂治疗腹泻型肠道易激综合征的临床疗效。69例腹泻型肠道易激综合征分为两组，治疗组36例口服谷参肠胺，对照组33例口服芽胞杆菌类制剂。治疗组和对照组的显效率和总有效率及随访半年的有效率，分别为55，6％，86，1％，80，6％和30．3％，72．7％，57．6％，两组显效率差异有统计学意义（P〈0，05），总有效率差异无统计学意义（P〉0，05），随访半年后的总有效率差异有统计学意义（P〈0，05），表明谷参肠胺治疗腹泻性肠道易激综合征优于芽胞杆菌类制剂，且无明显副作用，安全方便。

The objective of the study was to compare me merapeutic effect of Gu shen chang An（GSCA） and bacillus agents in the treatment of irritable bowel syndrome（IBS）. Patients with IBS of diarrheal type were divided into two groups,group A（36 cases）received GSCA for oral intake,while group B （33 cases）received bacillus agents for oral intake. As resulits, the generat rate, notably effective rate and half-year effective rate in the two groups were 86. 1%,55. 6%,80.6% （group A）and 72.7%,30.3%,57.6% （group B）. The difference of notably effective rate of the two groups had statistic value（ P〈0. 05）,and that of half-year general effective rate also had statistic significance（ P〈0.05） ,while the genera effective rate had no statistic significance（ P〉0.05）. It is suggested that GSCA is better in the treatment of diarrheal type IBS,and safe in application,no notably side effect.